Medications

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

Medications

FDA reviewers give thumbs down to new ALS drug

Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for amyotrophic lateral sclerosis (ALS).

Immunology

How sugar promotes inflammation

People who consume sugar and other carbohydrates in excess over a long period of time have an increased risk of developing an autoimmune disease. In affected patients, the immune system attacks the body's own tissue and the ...

Medications

FDA warns of rising dangers of unapproved drug tianeptine

The U.S. Food and Drug Administration (FDA) has issued another pointed warning about the dangers posed by tianeptine, an antidepressant that is not approved for any type of medical treatment in the United States.

Health

Evidence links the carotenoid lutein with eye health

Although the carotenoid lutein and its related form called zeaxanthin have been associated with eye health for some time, the amount that provides benefit has yet to be quantified.

page 12 from 40